Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. White
Consumerism and community participation: a reassessment of process, impact and value
NHS Management Executive
Local Voices: The Views of Local People in Purchasing for Health
S. Harrison (2002)
New Labour, Modernisation and the Medical Labour ProcessJournal of Social Policy, 31
C. Hogg
Patients, Power and Politics
J. Raftery (2001)
NICE: faster access to modern treatments? Analysis of guidance on health technologiesBMJ : British Medical Journal, 323
D. Sackett (2018)
Evidence-Based Medicine: How to Practice and Teach EBM
Consumers’ Association
National Institute for Clinical Excellence: A Patient‐centred Inquiry
Department of Health
Faster Access to Modern Treatment: How NICE Appraisals Will Work
NICE
Appraisal of Beta Interferon and Glatiramer Acetate for the Treatment of Multiple Sclerosis. Final Appraisal Determination
S. Harrison, G. Dowswell, T. Milewa (2002)
Guest editorial: public and user 'involvement' in the UK National Health Service.Health & social care in the community, 10 2
P. Quennell (2001)
Getting their say, or getting their way? Has participation strengthened the patient "voice" in the National Institute for Clinical Excellence?Journal of management in medicine, 15 3
L. Eaton
A dose of scepticism
NICE
Supplementary Submission to the House of Commons Health Select Committee (Papers 1 and 2)
D. Sackett, S. Straus, W. Richardson, W. Rosenberg, R. Haynes
Evidence‐based Medicine: How to Practise and Teach EBM (2nd ed.)
S. Harrison, G. Dowswell, T. Milewa
Public and user ‘involvement’ in the UK National Health Service
S. Kendrick (2001)
Using all the evidence: towards a truly intelligent National Health Service.Health bulletin, 59 2
D. Koenig, M. Edelman (1973)
Politics as Symbolic Action.Contemporary Sociology, 2
Department of Health
The NHS Plan: A Plan for Investment: A Plan for Reform
Department of Health
Cost‐Effective Provision of Disease‐Modifying Therapies for People with Multiple Sclerosis
NICE
Guidance for Patient/Carer Groups on Making a Submission to a Technology Appraisal
This paper examines patient organisations’ participation in the technology appraisals process of the National Institute for Clinical Excellence (NICE). In particular, it considers two policy areas prominent in recent UK government health reforms – patient participation and evidence‐based medicine (EBM). Data have largely been obtained from unstructured interviews with patient/carer groups involved in NICE’s technology appraisals, patient/carer representatives from NICE’s committees, and NICE personnel, supplemented by observation of NICE’s Board and Partners’ Council meetings, and analysis of documentary evidence. The paper focuses on the nature of “evidence” in NICE’s appraisals process, in particular patient groups’ concerns about the relative “weights” attached to patient and scientific evidence. NICE has taken some steps to allay such concerns, but more clarity is needed about how evidence from disparate sources is handled, if patient groups are to feel that their submissions of evidence have had more than marginal impact.
Clinical Governance An International Journal – Emerald Publishing
Published: Mar 1, 2003
Keywords: Patients’ expectations; Groups; Clinical effectiveness
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.